François Devin

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

Yuichiro Ogura, Johann Roider, Jean‐François Korobelnik et al. · American Journal of Ophthalmology · 2014 · 158 citations

Ocular Disease, Vitreous Body, Ophthalmology +6

Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration

Glenn J. Jaffe, Thomas A. Ciulla, Antonio P. Ciardella et al. · Ophthalmology · 2016 · 146 citations · Full text

Ocular Disease, Angiogenesis, Ophthalmology +7

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 124 citations · Full text